Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
Ruth Gershoni‐Baruch(Technion – Israel Institute of Technology), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), X. Chen(QIMR Berghofer Medical Research Institute), Ofra Barnett‐Griness(Carmel Medical Center), Guillermo Pita(Spanish National Cancer Research Centre), Fergus J. Couch(Mayo Clinic), Kathleen Claes(Statistics Belgium), Noralane M. Lindor(Mayo Clinic in Arizona), Eitan Friedman(University of Pennsylvania), Flavio Lejbkowicz(Carmel Medical Center), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Ana Osório(Spanish National Cancer Research Centre), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Roger L. Milne(The University of Melbourne), Lenka Foretová(Masaryk Memorial Cancer Institute), H Ozçelik(Mount Sinai Hospital), Tair Kontorovich(Sheba Medical Center), Bella Kaufman(NYU Langone Health), Irene L. Andrulis(University of Toronto), Yuan Chun Ding(University of Copenhagen), Nayana Weerasooriya, PL Mai(Odense University Hospital), Csilla I. Szabo(University of Delaware), Jacques Simard(Université Laval), Susan L. Neuhausen(City of Hope), Laura Tizzoni(Carmel Medical Center), Michal Zikán(Charles University), Gad Rennert(Technion – Israel Institute of Technology), Tuomas Heikkinen(University of Helsinki), Mark H. Greene(Cancer Institute (WIA)), Jonathan Beesley(The University of Melbourne), Paolo Peterlongo(IFOM), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Monica Barile(European Institute of Oncology), Yael Laitman(Sheba Medical Center), Sue Healey(QIMR Berghofer Medical Research Institute), Mads Thomassen(Odense University Hospital), D. G. Crüger(Vejle Sygehus), S. I. Cohen(Sheba Medical Center), X. Wang(Charles University), Alessandra Viel(Centro di Riferimento Oncologico)
Cited by 14
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k